[Clinico-experimental characteristic of the new cardiac glycoside homphotin].
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002301:Cardiac Glycosides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002306:Cardiac Volume; D003327:Coronary Disease / Q000188:drug therapy; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D010701:Phonocardiography; D011208:Powders; D013607:Tablets
D002301:Cardiac Glycosides; D011208:Powders; D013607:Tablets
Kliniko-eksperimental'naia kharakteristika novogo serdechnogo glikozida gomfotina.